OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 162 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $41,000 | -96.1% | 72,654 | -88.0% | 0.00% | -100.0% |
| Q4 2015 | $1,040,000 | +0.2% | 604,684 | +22.9% | 0.00% | 0.0% |
| Q3 2015 | $1,038,000 | +213.6% | 491,859 | +636.1% | 0.00% | – |
| Q2 2015 | $331,000 | -48.1% | 66,820 | -18.0% | 0.00% | -100.0% |
| Q1 2015 | $638,000 | +34.0% | 81,501 | +3.8% | 0.00% | 0.0% |
| Q4 2014 | $476,000 | +39.2% | 78,544 | -2.3% | 0.00% | 0.0% |
| Q3 2014 | $342,000 | -24.8% | 80,424 | +9.4% | 0.00% | 0.0% |
| Q2 2014 | $455,000 | -7.9% | 73,533 | -3.3% | 0.00% | 0.0% |
| Q1 2014 | $494,000 | +20.8% | 76,076 | +4.8% | 0.00% | 0.0% |
| Q4 2013 | $409,000 | -10.9% | 72,575 | -3.1% | 0.00% | 0.0% |
| Q3 2013 | $459,000 | +0.9% | 74,878 | -3.8% | 0.00% | 0.0% |
| Q2 2013 | $455,000 | – | 77,809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 1,900,000 | $11,106,000 | 1.50% |
| Redmile Group, LLC | 1,190,440 | $6,958,000 | 1.23% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 613,560 | $3,586,000 | 0.63% |
| Montibus Capital Management LLC | 818,575 | $4,784,570,000 | 0.60% |
| KOPP INVESTMENT ADVISORS LLC | 213,752 | $1,249,000 | 0.49% |
| PFM Health Sciences, LP | 3,646,260 | $21,312,000 | 0.44% |
| APEX CAPITAL, LLC | 1,092,900 | $6,388,000 | 0.44% |
| FIRST MANHATTAN CO. LLC. | 6,141,636 | $46,860,000 | 0.32% |
| JHL Capital Group LLC | 300,000 | $1,755,000 | 0.27% |
| Partner Investment Management, L.P. | 188,732 | $1,103,000 | 0.25% |